• 5 ASX shares downgraded by Morgans post-results

    A middle-aged lady screws her face up into a wince as though imaging an uncomfortable or awkward scenario.

    S&P/ASX 200 Index (ASX: XJO) shares are down 0.33% at 9,046 points on Tuesday.

    With reporting season now wrapped up, a number of companies have been downgraded by the experts following their FY26 results.

    Let’s find out why Morgans cut its ratings on the following 5 ASX shares.

    Mineral Resources Ltd (ASX: MIN)

    The Mineral Resources share price is $63.76, down 1.4% today and up 73% over 12 months. 

    Morgans lowered its rating on this ASX 200 mining share from buy to accumulate after reviewing the FY26 numbers.

    The broker raised its 12-month share price target from $68 to $71.

    This implies an 11% potential upside ahead.

    Morgans said:

    MIN delivered a strong FY26 result and FY27 guidance. Underlying NPAT was an 8% beat vs expectations and MIN declared a final dividend of 83cps (vs consensus 7.4cps).

    The stock gave back its early gains post the conference call after MIN flagged copper as a next potential growth pathway which we think unsettled some investors.

    South32 Ltd (ASX: S32)

    The South32 share price is $5.24, up 1.5% today and up 92% over 12 months.

    Morgans downgraded the ASX 200 mining share from accumulate to hold following South32’s FY26 report.

    The broker increased its 12-month price target from $4.70 to $4.90.

    This suggests a potential 6% downside ahead.

    Morgans said:

    S32 delivered a broadly in line FY26 result, with FY27 guidance on unit cost and capex reflecting existing market expectations of continued cost pressure.

    Don’t count on S32 returning a meaningful part of the Alcoa deal proceeds, with the company going as far as talking down its commitment to its ordinary dividend.

    Similar to some of its peers, S32’s earnings have enjoyed a healthy upcycle, our concern is that it is starting to increasingly look factored in (while the company arguably swaps its earnings clout for a mid-cycle M&A war chest post Alcoa deal).

    With S32’s share price outperforming even its pure-copper ASX peers year-to-date on larger cycle leverage, we downgrade our rating to HOLD (from Accumulate).

    Paladin Energy Ltd (ASX: PDN)

    The Paladin Energy share price is $11.66, up 0.4% today and up 44% over 12 months.

    Morgans downgraded the ASX 200 energy share from buy to accumulate following the uranium miner’s FY26 results.

    The broker has a 12-month price target of $14.10, implying a 20% upside from here.

    Cash is starting to flow — PDN delivered positive operating cash flow for the first full year since the restart, generating US$38m in FY26 and marking the transition from ramp-up story to steady-state and cash-generating producer.

    Guidance beaten across the board – Langer Heinrich Mine (LHM) exceeded FY26 production, sales and cost guidance, providing further evidence that the operation can sustainably deliver and continues to build momentum as it enters more steady state operations.

    Following recent share price strength, we move to an ACCUMULATE (previously BUY) with an increased price target of A$14.10ps.

    Lovisa Holdings Ltd (ASX: LOV)

    The Lovisa share price is $24.73, down 3.9% today and down 41% over 12 months.

    Morgans downgraded the ASX 200 retail share from buy to accumulate after its FY26 report.

    The broker shaved its 12-month price target from $32.50 to $31.

    This indicates potential capital gains of 25% over the next year. 

    Morgans said:

    LOV delivered a strong FY26 result, with EBIT up 14.1%, ~4.5% ahead of consensus. Excluding estimated ~$22m of EBIT losses from Jewells UK, the underlying business would have grown just shy of 30% yoy.

    The global store rollout continues, opening 160 stores in FY26, with management expecting a similar number in FY27.

    Trading in the first 8 weeks of FY27 was positive (+3% LFL), against a challenging comp in the pcp (+5.6%).

    Our valuation lowers to $31.00 and we move to an ACCUMULATE (from BUY) following recent strength in the share price.

    Nanosonics Ltd (ASX: NAN)

    The Nanosonics share price is $2.72, down 1.6% today and down 36% over 12 months.

    Morgans downgraded the ASX 300 healthcare share from buy to accumulate after reviewing Nanosonics’ FY26 report.

    The broker lowered its 12-month price target from $4 to $3.50.

    This suggests a potential near-30% upside ahead.

    Morgans said:

    Mixed result. Our key focus was whether 2H delivered the guided growth acceleration, it didn’t, but trophon-only earnings confirmed the core business remains in excellent health regardless of the group-level miss and near-term OPEX requirements for the CORIS launch.

    Trophon’s demonstrated EBIT growth ex-CORIS underwrites the thesis regardless of near-term CORIS spend, and the FY27 guidance step-down reads to us as front-loaded investment to land the launch properly, not any deterioration in the longer-term opportunity.

    The post 5 ASX shares downgraded by Morgans post-results appeared first on The Motley Fool Australia.

    Should you invest $1,000 in South32 right now?

    Before you buy South32 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and South32 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa and Nanosonics. The Motley Fool Australia has recommended Lovisa and Nanosonics. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • The 5 best ASX 200 stocks to buy and hold in August revealed

    Hands reaching high for a trophy with a sunset in the background.

    After posting a new record high earlier in the month, the S&P/ASX 200 Index (ASX: XJO) closed up 1.1% in August, with plenty of help from a basket of surging ASX 200 stocks.

    Below we look at five of the best large-cap ASX shares to have bought at market close on 31 July and held through to 31 August.

    And all but one of our top performers have something in common.

    Can you guess what it is?

    Westgold Resources Ltd (ASX: WGX)

    Westgold Resources shares surged 34.7% in August, closing the month at $6.37.

    The ASX 200 gold stock was supported in part by a resurgent gold price. The yellow metal ended August trading for US$4,450 per ounce. That saw the gold price up 10% over the month, according to data from Bloomberg.

    Westgold also released a number of positive exploration and resource updates over the month. And the miner reported its full-year FY 2026 results on 28 August.

    Highlights included record revenue of $2.33 billion, up 79% year-on-year. And underlying net profit after tax (NPAT) of $480 million was up 452%.

    Regis Resources Ltd (ASX: RRL)

    Regis Resources shares leapt 36.3% in August to end the month trading for $8.30 each.

    Regis also will have benefitted from the rising gold price.

    And the ASX 200 stock released some strong FY 2026 results on 21 August.

    Regis Resources reported a 43% year on year increase in gold sales revenue to $2.35 billion. And on the bottom line the miner achieved a record NPAT of $715 million, up 181% from FY 2025.

    CSL Ltd (ASX: CSL)

    Moving away from ASX gold shares, for a moment, CSL shares also shot the lights out in August.

    Shares in the ASX biotech giant closed August trading for $171.57 each, up 39.4% for the month.

    CSL shares got a big lift on 18 August after the company released its FY 2026 results.

    The company reported a 1% year-on-year decline in revenue to US$15.8 billion. And underlying NPATA of US$3.1 billion was down 2%.

    But investors were favouring their buy buttons amid a rosier outlook for FY 2027.

    Following what they labelled a ‘reset year’, management said they steady revenue in FY 2027, with underlying NPAT forecast to grow by around 5%.

    Vault Minerals Ltd (ASX: VAU)

    Moving back into the gold space, Vault Minerals shares soared 39.8% in August, ending the month at $6.67 a share.

    On 20 August, Vault Minerals also spurred investor interest after it released some strong FY 2026 results.

    Highlights included a 31% year on year increase in revenue from metal sales to $1.88 billion. And Vault achieved a statutory NPAT of $278.4 million.

    Which brings us to…

    Genesis Minerals Ltd (ASX: GMD)

    The fifth ASX 200 stock you would have done well to buy and hold throughout August is Genesis Minerals.

    Shares in the Aussie gold miner closed out the month trading for $8.22, up a whopping 44.0% in August.

    Genesis Mineral released its FY 2026 results late in the day on 20 August.

    The company reported an 89% year on year increase in sales revenue to $1.74 billion. And the miner’s underlying NPAT was up 147% to $547 million.

    The post The 5 best ASX 200 stocks to buy and hold in August revealed appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you buy CSL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Could a September rate hike hurt your superannuation returns?

    Man and woman sitting at table with the man looking a bit puzzled at his laptop.

    Superannuation has had an excellent run of late, and a rate rise this month would be the first real test of it.

    The Reserve Bank of Australia meets on 29 September. Morgan Stanley expects a hike, which would be the first move higher in this cycle.

    Most Australians will not think about what that means for their retirement savings. But given the implications, this question is worth five minutes of your time.

    How your superannuation has actually performed

    The average superannuation fund did well in FY26.

    Chant West estimates the median growth fund returned around 9% in FY26, making it a fourth consecutive year of strong returns.

    International listed shares did most of the heavy lifting.

    Every asset class delivered a positive return over the year with the single exception of Australian real estate investment trusts.

    It’s important to compare this performance to two broadly-held ASX market ETFs.

    Vanguard Australian Shares Index ETF (ASX: VAS) tracks the S&P/ASX 300 Index across 321 securities for a fee of 0.07% a year.

    The fund returned 5.79% over the year to 31 July 2026 and 8.92% annually across the past decade.

    Vanguard Australian Shares High Yield ETF (ASX: VHY) is far more concentrated, holding 92 companies led by Commonwealth Bank, BHP Group and the other major banks.

    Its forecast yield is 4.2%, or 5.5% once franking credits are counted, and it returned 17.87% over the year to 31 July 2026.

    What a rate rise would actually do

    The Reserve Bank held the cash rate at 4.35% on 11 August.

    Its statement left little doubt about the direction of future interest rates.

    The Board will continue to do what it considers necessary to bring inflation sustainably back to target, including increasing the cash rate target further if upside risks materialise.

    However, not everyone agrees the move comes this month.

    For example, Westpac chief economist Luci Ellis sees November as the more likely date.

    A hike would hit a superannuation fund in three places.

    Bond prices fall when yields rise, so the defensive part of your portfolio takes an immediate mark-to-market hit.

    Australian real estate investment trusts and infrastructure assets are repriced lower, because their long-dated cash flows are worth less.

    Bank shares face slower credit growth and higher deposit costs, and they are a very large part of the local index.

    The parts of your superannuation that would hold up

    Not everything suffers.

    Cash and term deposit allocations earn more, which helps anyone in a conservative or pension-phase option.

    Similarly, resources companies are largely driven by commodity prices rather than domestic rates.

    And then there are global equities, which are the biggest single driver of most balanced funds, and which respond to United States policy far more than Australian policy.

    What I would not do

    Switching your superannuation to cash ahead of a possible rate rise is the classic mistake.

    You crystallise any loss, you miss the recovery, and you have to be right twice to come out ahead.

    For investors who care about long-term returns, time in the market is much more important than timing the market.

    Foolish takeaway

    A September rate rise would trim returns, not wreck them.

    Bonds and rate-sensitive Australian shares would take the hit, while cash and global equities would cushion it.

    If your superannuation sits in a default balanced option and you have twenty years to run, the correct response is almost certainly nothing at all.

    If you are drawing an income and are heavily weighted toward bank shares, it may be worth checking your allocation.

    Either way, the decision should reflect your time horizon, which is usually much longer term than a single rate decision.

    The post Could a September rate hike hurt your superannuation returns? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Vanguard Australian Shares Index ETF right now?

    Before you buy Vanguard Australian Shares Index ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Vanguard Australian Shares Index ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group and Vanguard Australian Shares High Yield ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sorry, but nothing was found. Please try a search with different keywords.